Telegraph Hill Partners - aVenture Asset Manager Research
Location
San Francisco, CA, US
Founded
2002
Telegraph Hill Partners is a private equity firm specializing in life science, medical device, and healthcare companies in the United States. The firm typically invests across various stages, including Series A, B, and later rounds, with a focus on growth-stage opportunities. Their investment strategy encompasses a wide range of healthcare-related sectors, demonstrating a commitment to advancing innovative technologies and solutions in these fields.
Notable portfolio companies include Akoya Biosciences, Carterra, and RareCyte, reflecting the firm's emphasis on cutting-edge life science and medical technologies. Telegraph Hill Partners provides not only capital but also strategic guidance and industry expertise to help portfolio companies accelerate growth and achieve market leadership. The firm's investment approach is characterized by a hands-on partnership model, leveraging their deep sector knowledge to support portfolio companies' development and expansion.
Telegraph Hill Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
